Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | monoglyceride lipase | Starlite/ChEMBL | References |
Rattus norvegicus | Monoglyceride lipase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | monoglyceride lipase, putative | 0.0168 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Possible lysophospholipase | 0.0168 | 0.5 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0168 | 0.5 | 0.5 |
Leishmania major | monoglyceride lipase, putative | 0.0168 | 0.5 | 0.5 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0168 | 0.5 | 0.5 |
Plasmodium falciparum | esterase, putative | 0.0168 | 0.5 | 0.5 |
Mycobacterium leprae | POSSIBLE LYSOPHOSPHOLIPASE | 0.0168 | 0.5 | 0.5 |
Plasmodium vivax | PST-A protein | 0.0168 | 0.5 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0168 | 0.5 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0168 | 0.5 | 0.5 |
Plasmodium falciparum | lysophospholipase, putative | 0.0168 | 0.5 | 0.5 |
Mycobacterium ulcerans | lysophospholipase | 0.0168 | 0.5 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0168 | 0.5 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0168 | 0.5 | 0.5 |
Trypanosoma cruzi | monoglyceride lipase, putative | 0.0168 | 0.5 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0168 | 0.5 | 0.5 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0168 | 0.5 | 0.5 |
Plasmodium falciparum | lysophospholipase, putative | 0.0168 | 0.5 | 0.5 |
Trichomonas vaginalis | valacyclovir hydrolase, putative | 0.0168 | 0.5 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0168 | 0.5 | 0.5 |
Plasmodium falciparum | lysophospholipase, putative | 0.0168 | 0.5 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0168 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | > 4 | Inhibition of rat brain membrane FAAH assessed as [3H]-anandamide hydrolysis after 10 mins by liquid scintillation spectroscopy | ChEMBL. | 22185522 |
IC50 (binding) | > 5 | Inhibition of human recombinant his-tagged MAGL expressed in Escherichia coli assessed as hydrolysis of 4-nitrophenyl acetate after 20 mins by microplate reader | ChEMBL. | 22185522 |
IC50 (binding) | = 6.06 | Inhibition of rat brain cytosolic MAGL assessed as [3H]-2-arachidonoyl glycerol hydrolysis after 10 mins by liquid scintillation spectroscopy | ChEMBL. | 22185522 |
IC50 (binding) | = 0.87 uM | Inhibition of rat brain cytosolic MAGL assessed as [3H]-2-arachidonoyl glycerol hydrolysis after 10 mins by liquid scintillation spectroscopy | ChEMBL. | 22185522 |
IC50 (binding) | > 10 uM | Inhibition of human recombinant his-tagged MAGL expressed in Escherichia coli assessed as hydrolysis of 4-nitrophenyl acetate after 20 mins by microplate reader | ChEMBL. | 22185522 |
IC50 (binding) | > 100 uM | Inhibition of rat brain membrane FAAH assessed as [3H]-anandamide hydrolysis after 10 mins by liquid scintillation spectroscopy | ChEMBL. | 22185522 |
Inhibition (binding) | = 22 % | Inhibition of human recombinant his-tagged MAGL expressed in Escherichia coli assessed as hydrolysis of 4-nitrophenyl acetate at 10 uM after 20 mins by microplate reader | ChEMBL. | 22185522 |
Inhibition (binding) | = 25 % | Inhibition of rat brain membrane FAAH assessed as [3H]-anandamide hydrolysis at 100 uM after 10 mins by liquid scintillation spectroscopy | ChEMBL. | 22185522 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.